We are adding a niche medical device company to our Run to One (R21) Model Portfolio. It is an under-the-radar growth story where management believes the company’s specialized products, rapid...

One of my goals at GeoInvesting, as well as at my new Substack, is to continue to highlight some of the best investors in the microcap space to help all of us generate alpha. Hand-picking these...

A recent development has positioned a little-known company for what could be a significant transformation.  With a new customer that has the potential to double the size of the business and improve...

Fresh off our Live Open Forum reviewing December 2024, we are welcoming 2025 with continued optimism that microcaps will continue to perform well, especially in certain industries.  While we didn’t do...

We’re currently vetting a company in the defense industry that we believe may be uniquely positioned to benefit from the drone emergence by beginning to market existing technologies into the...

The Russell 2000 has come full circle, retracing all of its 9.1% gains achieved during the post-2024 election “Trump rally”. Initially, investors rushed to buy on optimism, only to reverse course...

So far, December has seen a bit of volatility across several microcap stocks that we actively follow. For example, the MSMqi has declined by approximately 6.25% from record highs reached in November...

As we continue to adjust to the evolving market landscape and subscriber feedback, we believe it is prudent to focus on more impactful investment strategies through a main high-conviction portfolio...

Overall, it was a slow week for news in our coverage universe. However, few earnings crossed the wire, but we’re particularly paying attention to one, which currently resides in our Run to $1 Model...